What is the Sequential Organ Failure Assessment (SOFA) score and how is it calculated?

Sequential Organ Failure Assessment (SOFA) Score

Definition and Purpose

The SOFA score is a validated tool that quantifies organ dysfunction across six organ systems (respiratory, cardiovascular, hepatic, coagulation, renal, and neurological), with each system scored 0-4 points based on objective clinical and laboratory parameters, yielding a total score of 0-24 points. 1, 2

The score was originally developed to sequentially assess the degree of multiple organ failure in critically ill patients with sepsis, enabling clinicians to track disease progression and response to treatment throughout the ICU stay. 3, 1

Scoring Components

Respiratory System (PaO₂/FiO₂ Ratio)

• 0 points: ≥400 mmHg 3
• 1 point: <400 mmHg 3
• 2 points: <300 mmHg 3
• 3 points: <200 mmHg with mechanical ventilation 3, 1
• 4 points: <100 mmHg with mechanical ventilation 3, 1

Cardiovascular System (Hemodynamics and Vasopressor Support)

• 0 points: Mean arterial pressure (MAP) ≥70 mmHg, no vasopressors 3
• 1 point: MAP <70 mmHg 3
• 2 points: Dopamine ≤5 μg/kg/min or dobutamine (any dose) 3
• 3 points: Dopamine >5 μg/kg/min OR epinephrine ≤0.1 μg/kg/min OR norepinephrine ≤0.1 μg/kg/min 3, 1
• 4 points: Dopamine >15 μg/kg/min OR epinephrine >0.1 μg/kg/min OR norepinephrine >0.1 μg/kg/min 3, 1

Hepatic System (Bilirubin Levels)

• 0 points: <1.2 mg/dL (<20 μmol/L) 3
• 1 point: 1.2-1.9 mg/dL (20-32 μmol/L) 3
• 2 points: 2.0-5.9 mg/dL (33-100 μmol/L) 3
• 3 points: 6.0-11.9 mg/dL (101-203 μmol/L) 3
• 4 points: >12 mg/dL (>203 μmol/L) 3, 1

Coagulation System (Platelet Count)

• 0 points: ≥150 × 10³/μL 3
• 1 point: <150 × 10³/μL 3
• 2 points: <100 × 10³/μL 3
• 3 points: <50 × 10³/μL 3
• 4 points: <20 × 10³/μL 3, 1

Renal System (Creatinine and Urine Output)

• 0 points: Creatinine <1.2 mg/dL (<106 μmol/L) 3
• 1 point: Creatinine 1.2-1.9 mg/dL (106-168 μmol/L) 3
• 2 points: Creatinine 2.0-3.4 mg/dL (169-300 μmol/L) 3
• 3 points: Creatinine 3.5-4.9 mg/dL (301-433 μmol/L) 3
• 4 points: Creatinine >5.0 mg/dL (>434 μmol/L) OR urine output <200 mL/day 3, 1

Note: 4 points may be assigned for renal replacement therapy, though this was not in the original scoring system. 3

Neurological System (Glasgow Coma Scale)

• 0 points: GCS 15 3
• 1 point: GCS 13-14 3
• 2 points: GCS 10-12 3
• 3 points: GCS 6-9 3
• 4 points: GCS <6 3, 1

Clinical Application and Interpretation

Sepsis Diagnosis

A SOFA score increase of ≥2 points from baseline in the presence of documented or suspected infection defines sepsis according to Sepsis-3 criteria. 1, 4

Prognostic Thresholds

• SOFA 0-6: Relatively low mortality risk in general ICU populations 1
• SOFA 7-8: Mortality risk increases substantially 1
• SOFA >10: Predicts mortality in >80-90% of cases 1
• SOFA >11: Mortality exceeds 90%; triggers discussions about goals of care and appropriateness of invasive interventions versus palliative measures 1

The area under the ROC curve for SOFA in predicting mortality is approximately 0.75-0.81, indicating acceptable to excellent discriminative ability. 3, 2, 5

Serial Monitoring Protocol

Calculate SOFA on ICU admission and reassess every 48-72 hours to track disease trajectory and treatment response. 1, 4

• Increasing scores: Signal treatment failure requiring escalation of care 1
• Decreasing scores: Indicate favorable response to interventions 6
• Delta SOFA (change from baseline to 72 hours): Provides valuable prognostic information, with increasing delta SOFA associated with higher mortality 5, 6

In a multicenter study of 544 ICU patients staying ≥1 week, the total SOFA score increased in 44% of nonsurvivors but only 20% of survivors (p<0.001), while it decreased in 33% of survivors compared with 21% of nonsurvivors (p<0.001). 6

Critical Limitations and Caveats

What SOFA Does NOT Include

SOFA does not incorporate patient age or chronic comorbidities, unlike APACHE II, which limits its predictive accuracy in certain populations. 3, 1, 2

Research demonstrates that adding age and comorbidity scores to SOFA (creating a "complemented SOFA" or cSOFA) improves the AUC from 0.743 to 0.812 for hospital mortality prediction. 7

Inappropriate Uses

• SOFA was not designed to categorize patients with low-moderate severity without sepsis or organ failure within the first 24 hours of hospital admission. 3, 2
• SOFA was not intended to indicate success or failure of specific interventions or to directly influence medical management decisions. 3
• Do not use SOFA alone for triage decisions in non-pandemic settings at low scores (<7), as it lacks validation for resource allocation at these thresholds. 1

Gastrointestinal and Immune Dysfunction

SOFA-2 does not incorporate gastrointestinal or immune dysfunction due to insufficient data and lack of content validity. 1

Comparison with Other Scoring Systems

In patients with complicated intra-abdominal infections, APACHE II demonstrated superior discriminative power (pooled AUC 0.81) compared to SOFA (AUC 0.75), though both performed acceptably. 3, 2 APACHE II was selected over SOFA for risk assessment in this population because it includes age and comorbidities and was specifically validated for mortality prediction across broader patient populations. 3

Practical Implementation

When to Calculate

• On ICU admission to establish baseline organ dysfunction 1, 2
• Every 48-72 hours during ICU stay to monitor progression 1, 4
• When clinical deterioration occurs to quantify worsening 1

Integration with Clinical Judgment

SOFA is a tool to augment, not replace, clinical judgment—always interpret scores in the context of the patient's clinical trajectory, baseline physiology, and response to interventions. 1

Automated Calculation

Electronic health record-based automated SOFA calculation is feasible and correlates highly with manually calculated scores (Spearman's rank correlation coefficient = 0.90), with similar predictive value for 30-day mortality (AUC 0.75 automated vs. 0.77 manual). 8 The renal and respiratory components show slightly lower agreement and may require manual verification. 8